SHIELD THERAPEUTICS PLC ORD 1.5 - stock earnings
STX.L Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q2 | -1.0 billion GBp | 351.5 million GBp |
| 2022Q4 | -2.9 billion GBp | 243.6 million GBp |
| 2022Q3 | -14.3 million GBP | 1.2 million GBP |
| 2022Q2 | -5.9 million GBp | 1.0 million GBp |
| 2022Q1 | -5.9 million GBp | 1.0 million GBp |
| 2021Q4 | -6.0 million GBp | 519000 GBp |
| 2021Q3 | -6.0 million GBp | 519000 GBp |
| 2021Q2 | -3.6 million GBP | 240500 GBP |
| 2021Q1 | -3.6 million GBP | 240500 GBP |
| 2020Q4 | -2.9 million GBP | 734000 GBP |
| 2020Q3 | -2.9 million GBP | 734000 GBP |
| 2020Q2 | 1.6 million GBP | 4.5 million GBP |
| 2020Q1 | 1.6 million GBP | 4.5 million GBP |
| 2019Q2 | -99.9 million GBp | 130.8 million GBp |
| 2019Q1 | -99.8 million GBp | 130.8 million GBp |
| 2018Q4 | 312.6 million GBp | 569.3 million GBp |
| 2018Q3 | 312.6 million GBp | 569.3 million GBp |
| 2018Q2 | -402.3 million GBp | 24.8 million GBp |
| 2018Q1 | -402.3 million GBp | 24.8 million GBp |
| 2017Q4 | -498.0 million GBp | 24.8 million GBp |
| 2017Q3 | -498.0 million GBp | 24.8 million GBp |
| 2017Q2 | -481.4 million GBp | 7.1 million GBp |
| 2017Q1 | -481.4 million GBp | 7.1 million GBp |
| 2016Q4 | -308.3 million GBp | 3.2 million GBp |
| 2016Q3 | -308.3 million GBp | 3.2 million GBp |
STX.L Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -4.0 billion GBp | 446.7 million GBp |
| 2021 | -1.9 billion GBp | 151.9 million GBp |
| 2020 | -263.0 million GBp | 1.0 billion GBp |
| 2019 | -880.0 million GBp | 71.9 million GBp |
| 2018 | -179.4 million GBp | 1.2 billion GBp |
| 2017 | -2.0 billion GBp | 63.7 million GBp |
| 2016 | -1.5 billion GBp | 30.4 million GBp |
| 2015 | -2.4 billion GBp | ? GBp |
| 2014 | -1.3 billion GBp | 24.4 million GBp |
STX.L
Price: £0.02
52 week price:
Earnings Per Share: -0.12 GBp
P/E Ratio: -0.50
Exchange: LSE
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 245529
Market Capitalization: 11.9 million